You are screening anticancer drugs for possible beneficial effects. You know that none of them is harmful, but you are uncertain whether they do any good. If your results are significant for a given drug, it will be the subject of further intensive investigation. If your results are not significant, the investigation will be dropped. Which type of error would you be more concerned about avoiding? Explain your answer.